Search Results

AstraZeneca WITHDRAWS COVID-19 injection worldwide after admitting it causes BLOOD CLOTS

6 days ago -

According to the National Pulse, the Anglo-Swedish drug firm applied for a withdrawal of its vaccine's marketing authorization in the European Union back in March. The European Medicines Agency (EMA), the agency in charge of regulating vaccines in the union, approved the request – which took effect on May 7. Similar moves in the U.K. and other countries were expected.

In an update on the EMA's website, it said the approval for the AstraZeneca COVID-19 injection had ...

AstraZeneca admits its COVID-19 vaccine CAUSES BLOOD CLOTS in U.K. court filings

12 days ago -

AstraZeneca's viral vector COVID-19 injection co-developed with the University of Oxford is sold under the brand names Covishield and Vaxzevria. But the injection was recalled in several countries due to the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) – blood clots coupled with a low blood platelet count.

While VITT has been accepted as a potential side effect for two years, the Telegraph reported that AstraZeneca's recent admission ...

AstraZeneca directs European Medicines Agency to revoke authorization for its own COVID-19 vaccine

5 days ago -

The EMA has followed suit and revoked authorization for AstraZeneca’s COVID-19 vaccine, (Vaxzevria and Covishield) - proving that European regulators wouldn’t dare criticize, let alone remove a vaccine from the market, unless the vaccine company directed them to do so.

This turn of events goes to show that the regulatory agencies are a façade and only acted in the best interest of the pharmaceutical industry from the start, endorsing bad science and promoting propaganda ...

AstraZeneca COVID injection pulled from market worldwide after admission of link to mysterious clots

10 days ago -

The reasons given have nothing to do with the health issues linked to the shot. Instead, scientists are claiming that newer versions of the jab targeting the latest "strains" and "variants" are now so widely available that AstraZeneca's injection is obsolete.

Back in March, AstraZeneca voluntarily pulled its COVID injection from the entire European Union (EU) market. Now, a couple months later, the European Medicines Agency (EMA) has officially unauthorized ...

AstraZeneca finally admits that their COVID-19 vaccine causes thrombosis with thrombocytopenia syndrome (TTS)

19 days ago -

As families bring their cases to court, lawyers representing AstraZeneca have had to face serious allegations that their vaccines are “defective” and cause life-threatening, blood-clotting injuries. For the first time, AstraZeneca admitted in a U.K. High Court that their COVID-19 vaccine causes thrombosis with thrombocytopenia syndrome (TTS). TTS is a medical condition where an individual suffers from a low platelet count and reoccurring blood clots.Over ...

AstraZeneca widow strikes out at the mainstream media…

July 20, 2022 -

(Article republished from Revolver.news)

This should be a major story, but of course, the mainstream media is downplaying the issue and playing it off as a one-off and a local news story.

The vaccine is still “safe and effective”, the Mockingbird media coos in unison.

Read her statement here via Twitter:

@bbcpress@Ofcom@BBCNews@BBCPanorama@gbnews@VIBUK1@[email protected]/8Oxo6tpbkT

— Vikki Spit, widowed at 38 by the AZ vaccine ...

AstraZeneca begins advanced trials for COVID-19 antibody medication

October 26, 2020 -

The two initial trials for the antibody-drug will assess its ability to prevent infections for as much as a year in some patients. The trials will also explore the drug's use as a preemptive treatment for patients exposed to SARS-CoV-2. Long-acting antibodies such as the ones used in AstraZeneca’s drug mimic the ones found in the human body; these have the potential to halt the effects of COVID-19 in infected patients. AZD7442 could also be used to complement a vaccine ...

COVID vaccine compensation claims totaling over $100M lodged against AstraZeneca

January 29, 2024 -

At least 40 more claims are expected to be lodged against the company. If AstraZeneca loses, the total compensation bill would amount to about 80 million pounds ($102 million).

The government of the United Kingdom has underwritten any legal action brought against AstraZeneca as part of its deal in rolling out the COVID-19 vaccine program, which received regulatory approval by the end of December 2021. Manufacturers of the other coronavirus vaccines ...

AstraZeneca vaccines cause DEVASTATING blood clots, peer-reviewed study confirms

August 25, 2021 -

Since the Oxford-AstraZeneca COVID-19 vaccine was first used in the United Kingdom in January of this year, it quickly became one of the most widely used COVID-19 vaccines in the world.

Unfortunately, the AstraZeneca vaccine has also become well-known for causing blood clots and other severe side effects. (Related: STUDY: Young people are twice as likely to die from AstraZeneca vaccine than from COVID-19.)

The peer-reviewed study -- the ...

AstraZeneca vaccine probed over death of BBC presenter Lisa Shaw

June 04, 2021 -

Newcastle's senior coroner Karen Dilks issued the interim fact-of-death certificate, which confirms that an investigation into Shaw's death will be held and that the "complication of AstraZeneca COVID-19 virus vaccination" is being considered as a possible cause.Shaw suffered blood clots days after getting first dose of AstraZeneca

Shaw's family said the 44-year-old was treated for blood clots days after receiving the first dose of AstraZeneca....

AstraZeneca vaccine creator says continual Covid vaccine booster shots are UNSUSTAINABLE

January 07, 2022 -

During a Jan. 3 interview with the Telegraph, Pollard argued that injecting people with booster shots every four to six months is an unsustainable endeavor. "We can't vaccinate the planet every four to six months. It's not sustainable or affordable. [If] your goal [with boosters] is to stop all infections, that is wrong," he said.

Instead, the scientist from the University of Oxford argued that vaccine rollouts should "target the vulnerable" instead of boosting entire ...

AstraZeneca may have provided “outdated” coronavirus vaccine data, safety board claims

March 25, 2021 -

The pharmaceuticals firm recently conducted a late-stage trial in the United States involving more than 32,000 volunteers. Efficacy data from the trial showed that the vaccine is 79 percent effective at preventing symptomatic COVID-19 and 100 percent effective at preventing severe illness and hospitalization, the firm announced on Monday, March 22.

Later that day, the DSMB notified the National Institutes of Allergy and Infectious Disease (NIAID), the Biomedical Advanced ...

AstraZeneca drops plan to seek US approval for its COVID-19 vaccine

November 13, 2022 -

Early on in the pandemic, the manufacturer applied for an emergency use authorization (EUA) with the U.S. Food and Drug Administration (FDA). However, the regulator refused to authorize the shot after its clinical trials showed a lack of elderly people. Of the 660 vaccinated participants older than 65 in the clinical trials, only two people caught COVID-19.

In addition, concerns about blood clots caused by the AstraZeneca COVID-19 vaccine was a huge factor ...

AstraZeneca ready to vaccinate half of Great Britain for coronavirus by SEPTEMBER

May 24, 2020 -

Reports indicate that drug giant AstraZeneca has been contracted by the United Kingdom to turn an experimental Wuhan coronavirus (COVID-19) vaccine developed by scientists at the University of Oxford into 30 million commercial doses of the jab before the fall.

United Kingdom Business Secretary Alok Sharma recently announced that a global licensing deal worth £130 million ($160 million) has been signed between Oxford and AstraZeneca. And the aim is to vaccinated ...